Goals & Objectives:

  • Attendees can identify manifestations of HUS
  • Attendees can describe difference between typical and atypical HUS
  • Attendees can identify considerations in patients receiving complement inhibition therapy
Session date: 
03/31/2026 - 12:00pm to 1:30pm CDT
Location: 
Comer Children's Hospital
5721 S. Maryland Ave
Rm K155
Chicago
United States
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Participation
Please login or create an account to proceed.
Speaker Name: 
Dr. Zain Talukdar